Captrust Financial Advisors Has $2.73 Million Stock Holdings in Synopsys, Inc. (NASDAQ:SNPS)

Captrust Financial Advisors lifted its position in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 12.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,629 shares of the semiconductor company's stock after purchasing an additional 635 shares during the period. Captrust Financial Advisors' holdings in Synopsys were worth $2,732,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also added to or reduced their stakes in the business. Kieckhefer Group LLC acquired a new position in Synopsys in the 4th quarter valued at approximately $27,000. Whipplewood Advisors LLC bought a new stake in shares of Synopsys in the fourth quarter worth $33,000. Pilgrim Partners Asia Pte Ltd acquired a new stake in Synopsys in the fourth quarter valued at $34,000. Sierra Ocean LLC acquired a new stake in Synopsys in the fourth quarter valued at $39,000. Finally, Hazlett Burt & Watson Inc. raised its position in Synopsys by 28.6% during the 4th quarter. Hazlett Burt & Watson Inc. now owns 90 shares of the semiconductor company's stock worth $44,000 after purchasing an additional 20 shares during the last quarter. Institutional investors own 85.47% of the company's stock.

Synopsys Stock Down 0.4%

NASDAQ SNPS opened at $482.69 on Monday. Synopsys, Inc. has a 52 week low of $365.74 and a 52 week high of $624.80. The business has a 50 day moving average price of $437.18 and a 200-day moving average price of $489.02. The company has a market cap of $74.63 billion, a price-to-earnings ratio of 33.24, a P/E/G ratio of 3.23 and a beta of 1.16.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on SNPS shares. Redburn Atlantic initiated coverage on Synopsys in a research note on Monday, January 13th. They issued a "buy" rating and a $600.00 price target for the company. Bank of America dropped their price target on shares of Synopsys from $630.00 to $560.00 and set a "buy" rating on the stock in a research report on Wednesday, April 16th. KeyCorp lowered their target price on shares of Synopsys from $690.00 to $555.00 and set an "overweight" rating for the company in a research note on Tuesday, April 15th. Mizuho cut their price target on shares of Synopsys from $650.00 to $600.00 and set an "outperform" rating on the stock in a research report on Tuesday, April 15th. Finally, Needham & Company LLC reissued a "buy" rating and issued a $650.00 price objective on shares of Synopsys in a research report on Thursday, February 27th. One equities research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company. According to MarketBeat, Synopsys currently has a consensus rating of "Moderate Buy" and a consensus price target of $613.43.

Insider Buying and Selling at Synopsys

In other Synopsys news, insider Geus Aart De sold 15,705 shares of the business's stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $444.42, for a total transaction of $6,979,616.10. Following the completion of the sale, the insider now directly owns 116,671 shares of the company's stock, valued at approximately $51,850,925.82. The trade was a 11.86% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Sassine Ghazi sold 11,366 shares of the stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $463.75, for a total value of $5,270,982.50. Following the completion of the sale, the chief executive officer now directly owns 70,922 shares of the company's stock, valued at approximately $32,890,077.50. This trade represents a 13.81% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.62% of the stock is currently owned by company insiders.

About Synopsys

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.